Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...
Florida's Todd Golden hopes a visit to his old coaching grounds will be just a brief stopover on the Gators' way back to the center of the college basketball stage. Meanwhile, Maryland hero Derik ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results